These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29202470)

  • 1. Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesis.
    Xiao Z; Baudry J; Cao L; Huang J; Chen H; Yates CR; Li W; Dong B; Waters CM; Smith JC; Quarles LD
    J Clin Invest; 2018 Jan; 128(1):157-174. PubMed ID: 29202470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ.
    Jang EJ; Jeong H; Kang JO; Kim NJ; Kim MS; Choi SH; Yoo SE; Hong JH; Bae MA; Hwang ES
    Br J Pharmacol; 2012 Mar; 165(5):1584-94. PubMed ID: 21913895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II.
    Xiao Z; Zhang S; Magenheimer BS; Luo J; Quarles LD
    J Biol Chem; 2008 May; 283(18):12624-34. PubMed ID: 18321855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystin-1 regulates bone development through an interaction with the transcriptional coactivator TAZ.
    Merrick D; Mistry K; Wu J; Gresko N; Baggs JE; Hogenesch JB; Sun Z; Caplan MJ
    Hum Mol Genet; 2019 Jan; 28(1):16-30. PubMed ID: 30215740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis.
    Qiu N; Cao L; David V; Quarles LD; Xiao Z
    PLoS One; 2010 Dec; 5(12):e15240. PubMed ID: 21151991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-specific deletion of Pkd2 leads to low-turnover osteopenia and reduced bone marrow adiposity.
    Xiao Z; Cao L; Liang Y; Huang J; Stern AR; Dallas M; Johnson M; Quarles LD
    PLoS One; 2014; 9(12):e114198. PubMed ID: 25464512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2.
    Matsumoto Y; La Rose J; Kent OA; Wagner MJ; Narimatsu M; Levy AD; Omar MH; Tong J; Krieger JR; Riggs E; Storozhuk Y; Pasquale J; Ventura M; Yeganeh B; Post M; Moran MF; Grynpas MD; Wrana JL; Superti-Furga G; Koleske AJ; Pendergast AM; Rottapel R
    J Clin Invest; 2016 Dec; 126(12):4482-4496. PubMed ID: 27797343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol.
    Byun MR; Jeong H; Bae SJ; Kim AR; Hwang ES; Hong JH
    Bone; 2012 Jan; 50(1):364-72. PubMed ID: 22108137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological mechanisms and therapeutic potential of bone mechanosensing.
    Xiao Z; Quarles LD
    Rev Endocr Metab Disord; 2015 Jun; 16(2):115-29. PubMed ID: 26038304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal Control of Osteogenic and Adipogenic Differentiation by ERK/MAP Kinase Phosphorylation of Runx2 and PPARγ Transcription Factors.
    Ge C; Cawthorn WP; Li Y; Zhao G; Macdougald OA; Franceschi RT
    J Cell Physiol; 2016 Mar; 231(3):587-96. PubMed ID: 26206105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic interactions between polycystin-1 and Wwtr1 in osteoblasts define a novel mechanosensing mechanism regulating bone formation in mice.
    Xiao Z; Cao L; Smith MD; Li H; Li W; Smith JC; Quarles LD
    Bone Res; 2023 Oct; 11(1):57. PubMed ID: 37884491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoidin Receptor 2 Controls Bone Formation and Marrow Adipogenesis.
    Ge C; Wang Z; Zhao G; Li B; Liao J; Sun H; Franceschi RT
    J Bone Miner Res; 2016 Dec; 31(12):2193-2203. PubMed ID: 27341689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanosensitive protein polycystin-1 promotes periosteal stem/progenitor cells osteochondral differentiation in fracture healing.
    Liu R; Jiao YR; Huang M; Zou NY; He C; Huang M; Chen KX; He WZ; Liu L; Sun YC; Xia ZY; Quarles LD; Yang HL; Wang WS; Xiao ZS; Luo XH; Li CJ
    Theranostics; 2024; 14(6):2544-2559. PubMed ID: 38646641
    [No Abstract]   [Full Text] [Related]  

  • 14. Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression.
    Xiao Z; Zhang S; Mahlios J; Zhou G; Magenheimer BS; Guo D; Dallas SL; Maser R; Calvet JP; Bonewald L; Quarles LD
    J Biol Chem; 2006 Oct; 281(41):30884-95. PubMed ID: 16905538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis.
    Dalagiorgou G; Piperi C; Adamopoulos C; Georgopoulou U; Gargalionis AN; Spyropoulou A; Zoi I; Nokhbehsaim M; Damanaki A; Deschner J; Basdra EK; Papavassiliou AG
    Cell Mol Life Sci; 2017 Mar; 74(5):921-936. PubMed ID: 27699453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis.
    David V; Martin A; Lafage-Proust MH; Malaval L; Peyroche S; Jones DB; Vico L; Guignandon A
    Endocrinology; 2007 May; 148(5):2553-62. PubMed ID: 17317771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interactions between Polycystin-1 and TAZ in osteoblasts define a novel mechanosensing mechanism regulating bone formation in mice.
    Xiao Z; Cao L; Smith MD; Li H; Li W; Smith JC; Quarles LD
    Res Sq; 2023 May; ():. PubMed ID: 37398127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.
    Xiong J; Almeida M; O'Brien CA
    Bone; 2018 Jul; 112():1-9. PubMed ID: 29626544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering small molecules that inhibit adipogenesis and promote osteoblastogenesis: unique screening and Oncostatin M-like activity.
    Nawa K; Ikeno H; Matsuhashi N; Ogasawara T; Otsuka E
    Differentiation; 2013; 86(1-2):65-74. PubMed ID: 23995451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
    Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
    PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.